大隐静脉：冠状动脉旁路移植术的第二移植物  

Saphenous vein graft： the second choice of conduits in coronary artery bypass grafting

作　　者：杨溢[1] 朱云鹏[1] 李海清[1] 蔡俊锋[1] 刘俊[1] 陈安清[1] 赵强[1] 

机构地区：[1]上海交通大学医学院附属瑞金医院心脏外科,200025

出　　处：《中华胸心血管外科杂志》2017年第4期253-256,共4页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：虽然冠状动脉旁路移植术中大隐静脉移植血管的远期通畅率不如动脉移植血管，但大隐静脉一直以来都是心脏外科医师青睐的常用旁路移植血管。近年来，得益于对静脉旁路移植血管病变病理机制不断认识、新型药物出现及手术技巧改良，其通畅率得到明显提高。本文阐述了静脉旁路移植血管的临床应用历史和现状、病变病理机制、提高通畅率的临床策略以及科研前景。Despite the fact that the patency rate of saphenous vein graft （SVG） is less than those of arterial grafts, SVG is fully appreciated by cardiac surgeons and remains the most widely-used conduit for coronary artery bypass grafting（CABG）. Recently, thanks to the growing understanding of the pathogenesis of vein graft failure（VGF） , the emergence of new drugs and the improvement of surgical techniques, the patency rate of SVG has been well improved. This article reviews the history and the current understanding of SVG, the pathogenesis of VGF, the clinical strategies that may improve the patency rate and the research prespeets in this filed.

关 键 词：冠状动脉旁路移植术 大隐静脉 移植物 静脉移植血管 旁路移植血管 静脉旁路移植 病理机制 血管病变 

分 类 号：R654.2[医药卫生—外科学]